Cargando…

Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation

Detalles Bibliográficos
Autores principales:	Di Bernardo, Maria Chiara, Broderick, Peter, Harris, Shelley, Dyer, Martin JS, Matutes, Estella, Dearden, Claire, Catovsky, Daniel, Houlston, Richard S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053357/ https://www.ncbi.nlm.nih.gov/pubmed/22814293 http://dx.doi.org/10.1038/leu.2012.173

Ejemplares similares

Deoxycoformycin in the treatment of mature T-cell leukaemias.
por: Dearden, C., et al.
Publicado: (1991)

Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk
por: Crowther-Swanepoel, Dalemari, et al.
Publicado: (2010)

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial
por: Oscier, David, et al.
Publicado: (2016)

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
por: Sava, G P, et al.
Publicado: (2015)

Regulation of HLA class I expression by non-coding gene variations
por: Bettens, Florence, et al.
Publicado: (2022)

Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
por: Olson, Eli, et al.
Publicado: (2023)

Long-term follow-up after purine analogue therapy in hairy cell leukaemia
por: Else, Monica, et al.
Publicado: (2015)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

Deoxycoformycin in the treatment of mature B-cell malignancies.
por: Dearden, C., et al.
Publicado: (1990)

Genetic predisposition to chronic lymphocytic leukemia
por: Law, Philip J., et al.
Publicado: (2019)

HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cells
por: Nyambura, Lydon Wainaina, et al.
Publicado: (2019)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
por: Suzuki, Daisuke, et al.
Publicado: (2019)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Successful treatment of hairy cell leukemia variant with obinutuzumab
por: Al-Sarayfi, Diana, et al.
Publicado: (2021)

HLA class I allele promiscuity revisited
por: Rao, Xiangyu, et al.
Publicado: (2011)

The pockets guide to HLA class I molecules
por: Nguyen, Andrea T., et al.
Publicado: (2021)

HLA-Clus: HLA class I clustering based on 3D structure
por: Shen, Yue, et al.
Publicado: (2023)

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
por: Kuželová, Kateřina, et al.
Publicado: (2018)

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
por: Speedy, Helen E., et al.
Publicado: (2019)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry
por: Matutes, E, et al.
Publicado: (2013)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Distribution of HLA class I alleles and haplotypes in Korean.
por: Kim, T. G., et al.
Publicado: (1993)

HLA class I alleles frequencies in the Syrian population
por: Ikhtiar, Adnan M., et al.
Publicado: (2018)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
por: Ruiz-Extremera, A., et al.
Publicado: (2017)

The Association of HLA-Class I and Class II with Hodgkin's Lymphoma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

HLA Class I and Class II Associations with ESRD in Saudi Arabian Population
por: Hamdi, Nuha Mahmoud, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
por: Zeestraten, E C M, et al.
Publicado: (2014)

The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021)

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia
por: Broccoli, Alessandro, et al.
Publicado: (2022)

Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11)
por: Mundhada, Shailendra, et al.
Publicado: (2004)

What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes
por: Wyatt, Rebecca C., et al.
Publicado: (2019)

Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism
por: Kandaswamy, Radhika, et al.
Publicado: (2016)

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
por: Giraudo, Lidia, et al.
Publicado: (2023)

HLA‐EMMA: A user‐friendly tool to analyse HLA class I and class II compatibility on the amino acid level
por: Kramer, Cynthia S. M., et al.
Publicado: (2020)

Isolated bone marrow amyloid light chain amyloidosis coexisting with multiple myeloma
por: Álamo Moreno, José R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hokbd8l38i8ftgkec63hjiv4qc